High-Sensitivity C-Reactive Protein as an Associate of Clinical Subsets and Organ Damage in Systemic Lupus Erythematosus
- 31 August 2008
- journal article
- Published by Elsevier BV in Seminars in Arthritis and Rheumatism
- Vol. 38 (1), 41-54
- https://doi.org/10.1016/j.semarthrit.2007.09.005
Abstract
No abstract availableKeywords
This publication has 73 references indexed in Scilit:
- Idiopathic Pulmonary Fibrosis Related to Endothelial Injury and Antiendothelial Cell AntibodiesHuman Immunology, 2006
- Treatment with combined oral contraceptives induces a rise in serum C‐reactive protein in the absence of a general inflammatory responseJournal of Thrombosis and Haemostasis, 2005
- Race and Gender Differences in C-Reactive Protein LevelsJournal of the American College of Cardiology, 2005
- C-Reactive protein levels among women of various ethnic groups living in the United States (from the Women's Health Study)The American Journal of Cardiology, 2004
- Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase proteinBlood, 2003
- Hepcidin, a Urinary Antimicrobial Peptide Synthesized in the LiverJournal of Biological Chemistry, 2001
- Inflammation enhances cardiovascular risk and mortality in hemodialysis patientsKidney International, 1999
- Elevation of Cerebrospinal Fluid Interleukin-6 Activity in Patients with Vasculitides and Central Nervous System InvolvementClinical Immunology and Immunopathology, 1993
- Interleukin-1 and Interleukin-6 Activities are Increased in the Cerebrospinal Fluid of Patients with CNS Lupus Erythematosus and Correlate with Local Late T-Cell Activation MarkersLupus, 1992
- Prevalence, Morphologic Types, and Evolution of Cardiac Valvular Disease in Systemic Lupus ErythematosusThe New England Journal of Medicine, 1988